Financials
- Market Capitalization 2.04 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.3
ratio cours/chiffre d'affaires
162.41
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1975 | ADMA ADMA Biologics Inc - Common Stock | 9.34 USD | -1.48% | -4.69% | +9.62% | -45.35% | 2.09 B USD | ||
| 1994 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +8.10% | +59.78% | 2.04 B USD | ||
| 2006 | ZYME Zymeworks Inc. - Common Stock | 28.27 USD | -2.55% | -1.40% | +28.38% | +59.36% | 2.01 B USD | ||
| 2007 | NBTX Nanobiotix S.A. - ADSs | 41.23 USD | -8.70% | +1.25% | +7.88% | +397.35% | 2.00 B USD |